Background/Aim: To compare overall survival (OS) and liver cancer-specific survival (LCSS)
of Surveillance, Epidemiology and End Results (SEER) hepatocellular carcinoma (HCC) …

Background: To compare outcomes for patients with colorectal cancer liver metastases (CRCLM)
treated by drug-eluting bead chemoembolization (DEB-TACE) or radioembolization (…

Aim: To compare toxicity, response, and survival outcomes of patients with hepatic
metastases from breast cancer who underwent transarterial chemoembolization (TACE) or …

Aim: Compare radioembolization (Y90) and chemoembolization (CE) for the treatment of
unresectable intrahepatic cholangiocarcinoma (UICC). Materials & methods: Institutional …

Aim: Compare ablation versus partial nephrectomy (PN) in T1A renal cell carcinoma (RCC)
treatment, using the SEER database. Methods: Patients with diagnosed T1A RCC from 2004 …

Aim: To compare overall survival (OS) and liver cancer-specific survival (LCSS) in patients
with localized hepatocellular carcinoma treated with surgical resection (SR) or thermal …

Objective: In this article, we seek to use a case-study discussion of a woman seeking treatment
guidance for an elective, complex surgical ailment to discuss how professionalism has …

Background and Objectives The liver is a frequent site of malignancy, both primary and
metastatic. The treatment goal of patients with liver cancer may include transarterial …

Aim: To compare the overall survival (OS) and liver cancer-specific survival of advanced-stage
hepatocellular carcinoma (HCC) patients who received transarterial radioembolization (…

Minimally invasive techniques in the treatment of cancer continue to develop at a rapid pace.
Although surgical resection currently remains the only option for a complete cure, not all …